BUNNIE WAX
DEAD

Serial Number

87255594

Owner

Reoxcyn Discoveries Group, Inc.

Attorney

Gregory B. Phillips

Filing Date

Dec 2, 2016

Add to watchlist:

No watchlists yet
View on USPTO

BUNNIE WAX Trademark

Serial Number: 87255594

BUNNIE WAX is a trademark filed by Reoxcyn Discoveries Group, Inc. on December 2, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Reoxcyn Discoveries Group, Inc. (12 trademarks)

1825 West Research Way, Suite A
West Valley City, UT 84119

Entity Type: 03

Trademark Details

Filing Date

December 2, 2016

Registration Date

Not Registered

Published for Opposition

October 24, 2017

Goods & Services

personal lubricants, medicated moisturizers, pharmaceutical products, pharmaceutical preparations, microbicides and drugs for medical purposes for treatment and prevention of sexually transmitted infections, viral, fungal and bacterial disease, namely, bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV), gonorrhea and syphilis; chemical and biological preparations, substances for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); reagents for medical purposes; pharmaceutical preparations containing polyvalent compounds, synthetic molecules and dendrimers for medical purposes for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); antimicrobial preparations, namely, microbicidial preparations in the nature of gels, foams, creams, films, solutions, suppositories, suspensions and lotions for vaginal, rectal and transdermal use for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS)

Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices treated with personal lubricants, moisturizers, pharmaceuticals, pharmaceutical preparations, microbicides and drugs for medical purposes for treatment and prevention of sexually transmitted infections, viral, fungal and bacterial disease, namely, bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV), gonorrhea and syphilis

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 23, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 23, 2018 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 19, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2017 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 14, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 23, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 23, 2017 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 11, 2017 GNRN
NON-FINAL ACTION E-MAILED
Feb 11, 2017 GNRT
NON-FINAL ACTION WRITTEN
Feb 11, 2017 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2016 NWOS
NEW APPLICATION ENTERED
Dec 6, 2016 NWAP